Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Search Results for 已驗證的CTAL-TTA_Syll19_4.0 考題資源和資格考試領導者和可靠的CTAL-TTA_Syll19_4.0:ISTQB Certified Tester Advanced Level - Technical Test Analyst (V4.0) 🌸 《 www.newdumpspdf.com 》是獲取⮆ CTAL-TTA_Syll19_4.0 ⮄免費下載的最佳網站CTAL-TTA_Syll19_4.0熱門認證

685 posts found

Increased Abuse Among Anti-Diarrhea Drugs

...This comes after reports of serious heart problems and deaths from much higher than recommended doses of loperamide. These adverse events are due to loperamide's increased use as a drug...
Read More

Could Psychedelic Injections Help with Mental Illness While Avoiding Hallucinogenic Effects?

...drugs that do not provide hallucinogenic effects – and possibly minimize more addictive elements. The new study tested if the psychedelic compound DOI (2,5-dimethoxy-4-iodoamphetamine) could reduce anxiety in mice by...
Read More

California Updates Pharmacy Fee Schedule

The California Division of Workers’ Compensation (DWC) adopted long-awaited Pharmaceutical Fee Schedule rules, introducing major changes to pharmaceutical billing and reimbursement. While there are many updates to the new rules,...
Read More

No End in Sight for the Opioid Epidemic?

...in the workers’ compensation industry have become experts in managing this particular area of concern, these latest numbers remind us that opioid management continues to be more important than ever....
Read More

California Releases Report on Independent Medical Reviews

The California Division of Workers' Compensation (DWC) released its annual report on the Independent Medical Review (IMR) program, managed by Maximus Federal Services. IMRs resolve disputes over treatment denials or...
Read More

NCCI Publishes Labor Market Insight Report

The National Council on Compensation Insurance (NCCI) released its latest Labor Market Insights report, offering a snapshot of current employment trends and their potential impact on workers’ compensation. By highlighting...
Read More

FDA Takes Steps to Streamline Biosimilar Development

...use data from a comparator product approved outside the U.S. as evidence that a proposed product is biosimilar to the U.S.-licensed product. The recommendations describe scenarios in which a biosimilar...
Read More

COVID-19 and Clinical Trials

Many clinical trials are underway for drugs to combat COVID-19, but the FDA gave special notice to two drugs. Gilead Sciences initiated two Phase 3 studies of the investigational antiviral...
Read More

New Autoimmune Biosimilar Approved and Alzheimer’s Drug Goes Generic

...Alzheimer’s could interfere with medication adherence, particularly if patients also have a comorbidity. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
Read More

Overcoming Obstacles to Patient Recovery Amid a Global Pandemic

Healthesystems’ VP of Clinical Services, Silvia Sacalis, BS, PharmD, was featured in the International Association of Industrial Accident Boards and Commissions’ (IAIABC) Perspectives publication. Dr. Sacalis penned an article on...
Read More

Hawaii Could Expand Firefighter Cancer Presumption

Hawaii House Bill 2387 was introduced, which would expand the currently existing cancer presumption for firefighters, and cover additional types of cancer under workers’ comp. For firefighters with five or...
Read More

Recapping the NCCI Annual Insights Symposium

Healthesystems' Advocacy and Compliance team recently attended the NCCI Annual Insights Symposium in Orlando, Florida. This event brings together executive leaders and actuaries from the workers' compensation industry to hear...
Read More

New Drugs, Generics, and a COVID-19 Treatment Update

...drug would be the first oral antiviral medication for COVID-19. For all of the latest updates on FDA drug approvals impacting workers’ comp, check out our interactive web tool, MedMonitor....
Read More

HIV Medications: New Approval and News of Discontinuations

...populations include healthcare workers. Recently, ViiV Healthcare, a GlaxoSmithKline company, communicated to the FDA that several HIV medications they manufacture will be discontinued by the end of 2023. While many...
Read More

Arizona Bill Could Expand Worker Choice in Medical Care

...care under A.R.S. § 23 1070 would remain unchanged. Additionally, the bill clarifies that initial compensation payments must be made no later than the 21st day after the Industrial Commission...
Read More
lockmap-markermagnifiercrossmenuarrow-rightcross-circle